[go: up one dir, main page]

UY34232A - Combinación antitumoral que comprende ombrabulina y cisplatino,asociada a radioterapia - Google Patents

Combinación antitumoral que comprende ombrabulina y cisplatino,asociada a radioterapia

Info

Publication number
UY34232A
UY34232A UY0001034232A UY34232A UY34232A UY 34232 A UY34232 A UY 34232A UY 0001034232 A UY0001034232 A UY 0001034232A UY 34232 A UY34232 A UY 34232A UY 34232 A UY34232 A UY 34232A
Authority
UY
Uruguay
Prior art keywords
ombrabulin
radiotherapy
cisplatin
antitumoral combination
antitumoral
Prior art date
Application number
UY0001034232A
Other languages
English (en)
Inventor
Carrez Chantal
Clemenson Celine
Deutsch Eric
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of UY34232A publication Critical patent/UY34232A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La invención se refiere a una combinación farmacéutica que comprende ombrabulina o AVE8062, que puede estar en forma de base o en forma de una sal farmacéuticamente aceptable y cisplatino, para su utilización como agente antitumoral destinado a pacientes tratados asimismo por radioterapia, que sufren especialmente cánceres y aún más particularmente atacados por tumores sólidos.
UY0001034232A 2011-08-01 2012-08-01 Combinación antitumoral que comprende ombrabulina y cisplatino,asociada a radioterapia UY34232A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1157040A FR2978662A1 (fr) 2011-08-01 2011-08-01 Combinaison antitumorale comprenant l'ombrabuline et le cisplatine, associee a la radiotherapie

Publications (1)

Publication Number Publication Date
UY34232A true UY34232A (es) 2013-02-28

Family

ID=46832546

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001034232A UY34232A (es) 2011-08-01 2012-08-01 Combinación antitumoral que comprende ombrabulina y cisplatino,asociada a radioterapia

Country Status (5)

Country Link
AR (1) AR087392A1 (es)
FR (1) FR2978662A1 (es)
TW (1) TW201313225A (es)
UY (1) UY34232A (es)
WO (1) WO2013018017A1 (es)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4259598A (en) 1979-12-20 1981-03-31 General Electric Company Charge transfer signal processing apparatus transversal filter
ES2267255T3 (es) * 1998-04-03 2007-03-01 Ajinomoto Co., Inc. Agentes antitumorales.
US20020183266A1 (en) 2001-03-15 2002-12-05 Aventis Pharma, S.A. Combination comprising combretastatin and anticancer agents
DK1407784T3 (da) 2001-06-25 2011-02-28 Ajinomoto Kk Antitumormidler
FR2838437B1 (fr) 2002-04-11 2004-06-04 Aventis Pharma Sa Procedes de preparation de combretastatines
GB0410817D0 (en) * 2004-05-14 2004-06-16 Angiogene Pharm Ltd Vascular damaging therapy
FR2895258B1 (fr) 2005-12-22 2008-03-21 Aventis Pharma Sa Combinaison comprenant de la combretastatine et des agents anticancereux
WO2009103076A1 (en) 2008-02-15 2009-08-20 Oxigene, Inc. Methods and compositions for enhancing the efficacy of rtk inhibitors
FR2945210B1 (fr) 2009-05-07 2011-07-01 Sanofi Aventis Combinaison antitumorale comprenant l'ave8062 et le sorafenib

Also Published As

Publication number Publication date
WO2013018017A1 (en) 2013-02-07
FR2978662A1 (fr) 2013-02-08
TW201313225A (zh) 2013-04-01
AR087392A1 (es) 2014-03-19

Similar Documents

Publication Publication Date Title
UY34820A (es) Compuestos tipo pirrolo-pirrolidinona
UY34550A (es) Bencilpirazoles sustituidos
UY4235Q (es) Configuración aplicada en zapato
UY4169Q (es) Altoparlante
UY4151Q (es) Vincha con auriculares
UY34547A (es) Un Escenario de Elevación Compuesto
UY34201A (es) Compuestos de azaindol y métodos para el tratamiento de vih.
UY34817A (es) Tienopirimidinas
UY34503A (es) ?sal de bromhidrato de pridopidina?
UY4281Q (es) Juguera
UY4210Q (es) Silla
UY4213Q (es) Centro de distribución de energía
UY34863A (es) Antagonistas de iap
UY4223Q (es) Banco
UY34590A (es) Fenilimidazopirazoles sustituidos y su uso
UY34677A (es) Imidazopiridazinas sustituidas
UY34153A (es) ?composición herbicida que comprende un herbicida piranodiónico y un herbicida sulfonilureico?.
UY33923A (es) Combinación antitumoral que comprende cabazitaxel y cisplatino
UY4242Q (es) Mesa
UY4233Q (es) Configuración aplicada en zapato
UY34232A (es) Combinación antitumoral que comprende ombrabulina y cisplatino,asociada a radioterapia
UY34233A (es) Combinación antitumoral que comprende ombrabulina y cetuximab,asociada a radioterapia
AU354730S (en) Roulette 73
UY4265Q (es) Automóvil
UY4461U (es) Proceso constructivo modular

Legal Events

Date Code Title Description
104 Application deemed to be withdrawn (no substantive examination fee paid)

Effective date: 20140528